Dennis R. Hill, MD to Present “Active Surveillance vs. High Dose Rate Brachytherapy” to the Summit Medical Staff Dennis R. Hill, MD Slated to Present “Active Surveillance vs. High Dose Rate Brachytherapy” at the Continuing Medical Education Conference for the Summit Medical Staff of the Alta Bates Summit Medical Center Thursday Oct 3 (PRWeb October 02, 2013) Read the full story at http://www.prweb.com/releases/2013/10/prweb11181942.htm
Oct. 2, 2013 - PRWeb
Nucletron, an Elekta Company, Receives US FDA 510(k) Clearance for Esteya Electronic Brachytherapy System for Treating ... STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Esteya®, an electronic brachytherapy system, has received 510(k) clearance from the US Food and Drug Administration (FDA), enabling medical centers in the United States to offer their patients with skin cancer a new treatment option. Esteya is a new approach for high precision skin cancer treatment. The system relies on a small, high dose rate ...
Oct. 2, 2013 - Business Wire